Author:
Nichols Russell M,Deveau Carmen,Upadhyaya Himanshu
Reference3 articles.
1. A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab;Hentzien;Lancet Infect Dis,2022
2. Bebtelovimab, alone or together with bamlanivimab and etesevimab, as a broadly neutralizing monoclonal antibody treatment for mild to moderate, ambulatory COVID-19;Dougan;medRxiv,2022
3. Neutralizing monoclonal antibodies for treatment of COVID-19;Taylor;Nat Rev Immunol,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献